Previous Article | Next Article 
Journal of Bacteriology, May 1999, p. 2846-2851, Vol. 181, No. 9
0021-9193/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
The Staphylococcus aureus rsbW
(orf159) Gene Encodes an Anti-Sigma Factor of SigB
Eishi
Miyazaki,1,2
Jong-Min
Chen,1,2
Chiew
Ko,1 and
William R.
Bishai1,2,3,*
Center for Tuberculosis Research, Department
of International Health,1 and Department
of Molecular Microbiology and Immunology,2 Johns
Hopkins School of Public Health, and Division of Infectious
Diseases, Department of Medicine, Johns Hopkins School of
Medicine,3 Baltimore, Maryland 21205-2179
Received 29 December 1998/Accepted 22 February 1999
 |
ABSTRACT |
SigB, a newly discovered alternative sigma factor of
Staphylococcus aureus, has been shown to play an important
role in stress responses and the regulation of virulence factors. The
rsbW (orf159) gene is immediately upstream of
sigB. Its gene product is homologous to Bacillus
subtilis RsbW which under appropriate conditions binds to
B. subtilis SigB and functions as an anti-sigma factor or
negative posttranslational regulator. To define the function of
S. aureus RsbW, both the S. aureus SigB and
RsbW proteins were expressed in Escherichia coli and
purified. Cross-linking experiments with these purified proteins
revealed that RsbW was capable of specific binding to SigB. In an in
vitro transcription runoff assay, RsbW prevented SigB-directed
transcription from the sar P3 promoter, a known
SigB-dependent promoter, and the inhibitory activity of RsbW was found
to be concentration dependent. We also identified SigB promoter
consensus sequences upstream of the genes encoding alkaline shock
protein 23 and coagulase and have demonstrated SigB and RsbW dependence
for the promoters in vitro. These results show that RsbW is a protein
sequestering anti-sigma factor of S. aureus SigB and
suggest that SigB activity in S. aureus is regulated posttranslationally.
 |
INTRODUCTION |
Staphylococcus
aureus is a major human pathogen that causes a variety of
diseases ranging from minor skin ailments to life-threatening deep
infections, such as endocarditis, meningitis, arthritis, and toxic
shock syndrome (26, 36, 39). The frequencies of both
community- and hospital-acquired staphylococcal infections have
increased steadily with little change in overall mortality (16). Treatment of these infections has become more
difficult because of the emergence of multidrug-resistant strains
(16, 37).
The virulence of S. aureus is dependent upon its
ability to respond to a wide range of host conditions during the
infection process. Transcriptional regulators such as sigma factors are likely to play an important role in the bacterial adaptive responses needed for pathogenesis (29). Indeed, alternative sigma
factors have been correlated with virulence in several pathogenic
species (13, 17, 18). Recently, an S. aureus
alternative sigma factor gene known as sigB was identified
within a four-gene operon (22, 40). With strong primary
amino acid similarity to SigB of Bacillus subtilis,
S. aureus SigB has been evaluated as a stress response and stationary-phase sigma factor and has been shown to be induced during stationary phase and upon heat shock (22).
Additionally, interruption of the S. aureus sigB gene
causes increased sensitivity to hydrogen peroxide during the stationary
growth phase (23). By in vitro transcription S. aureus SigB has further been shown to participate in the
transcription of the sar locus (12), which is
itself a key regulator of virulence gene expression (7, 8,
27). Furthermore, the expression of lipase and thermonuclease, which play important roles in abscess formation, have been associated with SigB control (23). Thus, SigB appears to participate
directly and indirectly in the expression of S. aureus
virulence genes.
While most sigma factors are themselves transcriptionally regulated,
posttranslational control by other proteins known as anti-sigma factors
also plays an important role in controlling their activity in some
instances (4, 5, 31). Anti-sigma factor proteins bind and
sequester a specific sigma factor, thus blocking transcription
initiation (5, 19). The B. subtilis RsbW
protein has been shown to function as an anti-sigma factor of the
stress response regulator SigB (4, 14, 19). The B. subtilis rsbW gene is located immediately upstream
of the sigB gene, and the two are cotranscribed.
B. subtilis RsbW and SigB demonstrate specific binding
by column chromatography and coimmunoprecipitation with monoclonal
antibodies to either protein (4). B. subtilis RsbW also efficiently blocked SigB-dependent
transcription in vitro. Recent DNA sequence analyses of the
S. aureus sigB operon revealed four complete open
reading frames (rsbU, rsbV, rsbW, and
sigB) with significant predicted amino acid homology and
gene arrangement to rsbU, rsbV, rsbW,
and sigB in B. subtilis (22, 40).
These similarities suggest that RsbW of S. aureus is an anti-sigma factor of S. aureus SigB. In this
report we demonstrate that S. aureus RsbW binds to
S. aureus SigB and inhibits SigB-dependent transcription. We also identify two possible new members of the S. aureus SigB regulon by demonstrating that the genes
for S. aureus alkaline shock protein 23 and coagulase
show SigB and RsbW dependence in vitro.
 |
MATERIALS AND METHODS |
Strains and plasmids.
The TA cloning vector pCRII was
purchased from Invitrogen Corp. (Carlsbad, Calif.). Escherichia
coli BL21(DE3) and the vector pET32b, used for protein
overexpression, were obtained from Novagen (Madison, Wis.). Isolation
and purification of plasmids were performed by using the Qiagen system
(Qiagen, Inc., Chatsworth, Calif.). S. aureus strains
ATCC 29213 and 8325-4 were used as sources of chromosomal DNA for the
PCR amplifications.
Construction of plasmids for overexpressing sigB and
rsbW (orf159).
A DNA fragment encoding 776 bp of the sigB gene was amplified by PCR with primers SAF005
(5'-ATCCATGGCGAAAGAGTCGAAATC-3') and SAR003
(5'-CGGATCCTATTGATGTGCTGCTTCTTG-3'); this PCR product was
cloned into pCRII, and the resulting plasmid was designated pEM101. The
sigB-overexpressing plasmid, pEM102, was the product of
cloning the NcoI-BamHI-digested fragment from
pEM101 with the same enzymes into pET32b.
pEM201 was constructed by cloning a 486-bp fragment containing the
rsbW (orf159) gene into pCRII. Oligonucleotides
ASAF001 (5'-CCATGGATGCAATCTAAAGAAGATTTT-3') and ASAR002
(5'-GGATCCTTAACTGATTTCGACTCTTTCGGC-3') were used to amplify
this PCR product. An NcoI-BamHI-digested fragment from pEM201 was inserted into pET32b digested with the same
enzymes to create the rsbW expression vector, pEM202.
Purification of SigB and RsbW fusion proteins.
pET32b-based,
His6-thioredoxin (Trx) fusion proteins were expressed and
purified according to the recommendations of the manufacturer (Clontech
Laboratories, Inc., Palo Alto, Calif.) with some modifications. E. coli BL21(DE3) transformed with pEM102, pEM202, and
pET32b (generating strains EMBL1, EMBL2, and EMBL3, respectively) was grown in 250 ml of Luria-Bertani medium containing ampicillin (100 µg/ml) at 37°C until the culture reached an optical density at 600 nm (OD600) of between 0.6 to 0.8. Induction with
isopropyl-
-D-thiogalactopyranoside (IPTG) at 1 mM was
conducted for 3 h, and then the cells were harvested, suspended in
10 ml of lysis buffer (50 mM NaH2PO4, 10 mM
Tris-HCl, 100 mM NaCl; pH 8), and lysed by sonication. After centrifugation at 12,000 rpm for 30 min, the resulting
supernatant was loaded onto a 2-ml column of metal affinity resin
(Clontech) equilibrated with sonication buffer. After exposure to
excess wash buffer (50 mM NaH2PO4, 100 mM
NaCl; pH 7), the Trx-tagged protein was eluted with elution buffer (50 mM NaH2PO4, 20 mM PIPES [piperazine-N,N1-bis(2-ethanesulfonic
acid)], 100 mM NaCl; pH 6) and dialyzed against a solution of 10 mM
Tris-HCl (pH 8), 50 mM KCl, 10 mM MgCl2, 0.4 mM,
dithiothreitol, and 20% glycerol. Protein concentrations were
determined with the Coomassie reagent (Pierce, Rockford, Ill.).
Purified protein was divided into aliquots and stored at
70°C.
[35S]methionine labeling of SigB and RsbW.
EMBL1, EMBL2, and EMBL3 cells were grown at 37°C in 20 ml of M9
minimal medium supplemented with 0.2% glucose, vitamin B1 (1 µg/ml),
and ampicillin (75 µg/ml) to an OD600 of 0.5; IPTG was
then added to 1 mM. After 30 min, rifampin was added to a final
concentration of 200 µg/ml for an additional hour. Then, 1-ml
aliquots of culture were labeled with 20 µCi of
[35S]methionine for 5 min and chased with unlabeled
excess methionine for an additional 5 min. The labeled cells were then
collected by centrifugation, washed, and frozen at
70°C. Cell
pellets from 1 ml of [35S]methionine-labeled cells
were resuspended in 0.5 ml of lysis buffer and lysed by repeated
freeze-thaw steps. Particulate matter was removed by centrifugation.
Preparation of crude cell lysates from EMBL3 cells.
Cultures
(25-ml each) of EMBL3 cells (harboring empty vector) were grown to an
OD600 of 0.6, induced with IPTG for 3 h, harvested, and frozen as pellets at
70°C. Before use, the pellets were
suspended in lysis buffer and sonicated. After centrifugation at 14,000 rpm for 15 min, the resulting supernatant was collected.
Chemical cross-linking reaction.
Chemical cross-linking was
carried out in 50-µl reaction mixtures containing 1 mM ethylene
glycol-bis(succinimidylsuccinate) (EGS) (Pierce), 5 to 10 µg of
extract containing 35S-labeled proteins from recombinant
E. coli, and unlabeled proteins at the following
concentrations: RsbW, 0.25 to 0.5 µg; SigB, 0.75 to 1.5 µg; crude
EMBL3 extract, 150 µg; or lysis buffer. The cross-linking reactions
were allowed to proceed for 3 h on ice and were terminated by the
addition of sodium dodecyl sulfate (SDS) gel loading dye and
L-lysine to 20 mM (final concentration). Samples were
boiled and separated by electrophoresis in SDS-10% polyacrylamide
slab gels. Gels were stained with Coomassie brilliant blue R-250,
impregnated with a scintillation fluor, dried, and analyzed by autoradiography.
In vitro transcription assay.
For RNA polymerase holoenzyme
reconstitution, purified SigB and E. coli core RNA
polymerase (Epicentre Technologies, Madison, Wis.) were coincubated at
37°C for 30 min. For inhibition experiments, SigB was preincubated
with purified RsbW, albumin, or dilution buffer prior to incubation
with the core RNA polymerase. Single runoff in vitro transcription
reactions were conducted by the sequential addition of template DNA,
nucleotides including [
-32P]CTP, and a mixture of
heparin and unlabeled CTP. Final concentrations in 40 µl of reaction
mixture were as follows: 10 mM Tris-HCl (pH 8), 50 mM KCl, 10 mM
MgCl2, 0.4 mM dithiothreitol, 0.25 mM ATP, 0.25 mM GTP,
0.25 mM TTP, 10 µCi of [
-32P]CTP, 0.25 mM CTP, 500 µg of heparin per ml, and 1.0 U of RNase inhibitor. Finally, 40 µl
of formamide loading dye was added to the sample. After being boiled,
the samples were loaded and electrophoresed in a 6% denaturing
polyacrylamide gel. Gels were analyzed immediately by
autoradiography. Template DNA fragments containing S. aureus promoters were prepared as follows: sar P3 (349 bp) was amplified with primers sarF01
(5'-GTATAGACACTTTAACGTGCT-3') and sarR02
(5'-ACAGTGATTGTATTTCTGGGT-3'); sar P1 (339 bp)
was amplified with primers sarF03 (5'-AAAGCGTTGATTTGGGTAGTA-3') and sarR04 (5'-AGCACGTTAAAGTGTCTATAC-3');
sar P2 (321 bp) was amplified with primers sarF05
(5'-TCGAAACATTTAATTGCGCTA-3') and sarR06
(5'-ACCTCCCTATTTGATGCATCT-3'); asp23 (320 bp) was
amplified with aspF1 (5'-GACTCTACACAACAAGTGATT-3') and aspR2
(5'-AGTTTGATTGTCGTATGCTTG-3'); and coa (300 bp)
was amplified with coaF1 (5'-CAAAAAGATAGTTAATGCTTTGTT-3') and coaR2 (5'-AGTCTTCCAAATAATATAGAGCTG-3'). Each DNA
fragment was gel purified prior to use in runoff assays.
 |
RESULTS |
Purification of SigB and RsbW proteins.
A pET32b-based
expression vector called pEM102 was constructed in which the T7
promoter was fused to the S. aureus sigB gene. Induction of E. coli BL21(DE3) harboring pEM102 with IPTG
led to high-level expression of soluble SigB fusion protein, as can be
seen in Fig. 1 (lane b). Affinity column chromatography gave Trx-tagged
SigB protein which migrated at an estimated molecular mass of 44 kDa on
SDS-polyacrylamide gel electrophoresis (PAGE) and was 90% pure (Fig.
1, lane c). The deduced molecular mass of untagged SigB is 29.4 kDa and that of the Trx-SigB fusion protein is 41.1 kDa (the mass of
the Trx moiety is 11.7 kDa).
RsbW protein was obtained by the same method, yielding large amounts of
soluble fusion protein in an IPTG-dependent manner (Fig.
1, lane e versus lane d). The purified
Trx-tagged RsbW protein migrated at an estimated molecular mass of 33 kDa on SDS-PAGE and was 90% pure (see Fig. 1, lane f). The deduced
molecular mass of untagged RsbW is 17.9 kDa, and the deduced total mass
of the fusion protein is 29.6 kDa.

View larger version (79K):
[in this window]
[in a new window]
|
FIG. 1.
Overexpression and purification of recombinant SigB and
RsbW proteins. SDS-10% PAGE gel analysis (25) of fractions
from the purification of SigB and RsbW. Lane M contains the molecular
mass markers (masses in kilodaltons are shown on the left). Cell
extracts from E. coli BL21(DE3) harboring pEM102 (Trx-SigB
overexpression) grown without IPTG induction (lane a), in the presence
of IPTG (lane b), and the affinity-purified Trx-SigB fusion protein
(lane c) are shown. Cell extracts from E. coli BL21(DE3)
harboring pEM202 (Trx-RsbW overexpression) grown without IPTG induction
(lane d), in the presence of IPTG (lane e), and with the
affinity-purified Trx-RsbW fusion protein (lane f) are shown.
|
|
Formation of SigB-RsbW complexes by chemical cross-linking.
After preparing Trx-tagged SigB and RsbW proteins in radioactive and
nonradioactive forms by E. coli overexpression, we tested for direct protein-protein interactions between SigB and RsbW by using
EGS. EGS is a bifunctional chemical cross-linking reagent which reacts to form covalent bonds with lysine residues spaced no more
than 11 Å apart. As may be seen in Fig.
2A, 35S-labeled, tagged SigB
migrates at 44 kDa on an SDS-polyacrylamide gel (Fig. 2A, lane h) and
does not form high-molecular-mass complexes in the presence of EGS
(Fig. 2A, lane d). Incubation of radioactive, tagged SigB extracts
with different amounts of unlabeled, purified RsbW in the
presence of EGS generated high-molecular-mass SigB-containing complexes
of over 97 kDa on an SDS-10% polyacrylamide gel (lane e and f). The
amount of radioactive SigB appearing in a high-molecular-weight complex
correlated directly with the amount of RsbW added to the mixture,
suggesting that it is a SigB-RsbW covalent aggregate.

View larger version (56K):
[in this window]
[in a new window]
|
FIG. 2.
Specific interaction between SigB and RsbW. (A)
35S-labeled, unfused Trx protein incubated in the presence
of EGS with lysis buffer (lane a) or with 0.25 µg (lane b) or 0.5 µg (lane c) of unlabeled RsbW are shown. Also shown are
35S-labeled, Trx-tagged SigB incubated in the presence of
EGS alone (lane d) or with 0.25 µg (lane e) or 0.5 µg (lane f) of
unlabeled RsbW in the presence of EGS. Lanes g and h show
35S-labeled, Trx-tagged SigB incubated in the presence of
EGS with cell extract from E. coli EMBL3 (lane g) and
35S-labeled, Trx-tagged SigB incubated in the absence of
EGS with 0.5 µg of RsbW (lane h). (B) 35S-labeled,
unfused thioredoxin (Trx) protein incubated in the presence of EGS with
lysis buffer (lane a) or with 0.75 µg (lane b) or 1.5 µg (lane c)
of unlabeled SigB. Remaining lanes show 35S-labeled,
Trx-tagged RsbW incubated in the presence of EGS alone (lane d) or with
0.75 µg (lane e) or 1.5 µg (lane f) of unlabeled SigB in the
presence of EGS; 35S-labeled Trx-tagged RsbW incubated in
the presence of EGS with cell extract from E. coli EMBL3
(lane g); and 35S-labeled, Trx-tagged RsbW incubated in the
absence of EGS with 1.5 µg of unlabeled SigB (lane h). Molecular
masses in kilodaltons are shown at the left.
|
|
To evaluate the specificity of complex formation, we tested the ability
of protein extracts lacking RsbW to complex with radiolabeled, tagged
SigB. Whole-cell extracts from EMBL3 (vector alone strain of
E. coli expressing only the Trx tag) incubated in the
presence of EGS with radioactive, tagged SigB failed to produce
high-molecular-weight complexes (Fig. 2A, lane g). To control for the
Trx tag on SigB, we also tested the ability of the radiolabeled Trx
polypeptide alone to cross-link with RsbW. When 0.75 or 1.5 µg of
purified tagged RsbW was incubated with radioactive Trx-containing
extracts in the presence of EGS, high-molecular-weight adducts did not form (Fig. 2A, compare lane a [no EGS] with lanes b and c [with EGS]). This experiment excludes the possibility that interactions between RsbW and the Trx tag are sufficient for cross-linking to occur.
Additionally, we performed the converse experiment in which
radiolabeled, tagged RsbW-containing E. coli extracts were
allowed to interact with nonradioactive, purified SigB in the
presence of cross-linker. E. coli extracts containing
35S-labeled, tagged RsbW produced a new 68-kDa band after
EGS treatment (Fig. 2B, lane d), while in the absence of EGS only a
33-kDa species was seen (Fig. 2B, lane h). This suggests that tagged
RsbW exists as a dimer, although we cannot exclude the possibility that
it binds to another protein of similar size derived from E. coli. RsbW also appeared to be able to form higher
self-aggregates, as may be seen by the faint high-molecular-weight
bands in Fig. 2B, lanes d and g. When purified, tagged SigB was added
to the extract containing radioactive, tagged RsbW in the presence of EGS, high-molecular-mass complexes running above the 97-kDa marker on
an SDS-10% polyacrylamide gel were observed (Fig. 2B, lanes e and f).
The intensity of the RsbW-containing complexes was dependent upon the
amount of tagged SigB added, strongly suggesting that it is a
SigB-RsbW covalent aggregate. As before, the specificity for
complex formation was tested by incubating radioactive Trx with
unlabeled SigB. No high-molecular-weight complexes were formed in
these control experiments (Fig. 2B, lanes a to c). These results indicate that S. aureus SigB and RsbW undergo a
relatively specific protein-protein interaction in vitro and that
conjugates between the two proteins may be trapped by using the
chemical cross-linker EGS.
Inhibition of SigB-directed transcription of sar by
RsbW.
PCR products (300 to 350 bp) corresponding to S. aureus promoters were used as templates for in vitro transcription
runoff assays. We first tested the three sar operon
promoters, including sar P3 (producing the
sarC transcript), which has been shown to be SigB dependent.
The expected sizes of the transcripts from sar P1,
sar P2, or sar P3 are 140, 167, or 194 bases, respectively. As shown in Fig. 3,
the sar P1 and sar P2 promoters failed to direct
transcription by core polymerase alone or holoenzyme E
B
(core polymerase reconstituted with Trx-tagged SigB) (Fig. 3, lanes a
to d). On the other hand, E
B generated a
transcript at 190 bases (Fig. 3, lane f), whereas core enzyme
alone failed to transcribe from the sar P3 promoter (Fig. 3,
lane e). In our single-round transcription assay, we occasionally
observed low-abundance bands smaller than the anticipated runoff
product when large amounts of SigB (
0.15 µg) were added to the core
enzyme (e.g., Fig. 3, lane f). These bands may result from stutter
products or from nonspecific binding due to the saturated state of the
promoter region when E
B is present at a high
concentration. We also tested whether the Trx tag present on the SigB
protein may have interfered with in vitro transcription. Untagged SigB
which had had the recombinant Trx tag removed by treatment with
enterokinase was found to be of equal potency with Trx-tagged sigma
factor in the in vitro transcription assay (data not shown). Hence, the
presence of the Trx tag on SigB appears to have little effect on the
activity of SigB.

View larger version (53K):
[in this window]
[in a new window]
|
FIG. 3.
In vitro transcription analysis of the sar
operon. Lane M, 32P-labeled DNA size markers. The sizes of
the individual DNA fragments in bases are indicated on the left. DNA
templates (0.02 µg) for the transcription reaction containing the
sar P1, P2, or P3 promoters were added to the reaction
mixtures. Lanes a and b were from mixtures containing P1; lanes c and d
were from mixtures containing P2; and lanes e and f were from mixtures
containing P3. The transcription reaction mixtures contained 0.4 U of
E. coli core RNA polymerase preincubated with 0.58 µg of
Trx-tagged SigB protein (lanes b, d, and f) or with dialysis buffer
(lanes a, c, and e). The products of transcription were subjected to
electrophoresis on a 6% denaturing polyacrylamide gel and visualized
by autoradiography. The arrow indicates the position of the 190-base
sar P3 transcript.
|
|
To examine whether RsbW would inhibit SigB-directed
transcription, we preincubated tagged SigB with various amounts
of purified, tagged RsbW before it was incubated with core RNA
polymerase. As may be seen in Fig. 4,
transcription generated by E
B was inhibited by the
addition of RsbW (Fig. 4, lanes c to e). When RsbW was added to SigB in
an equimolar amount, transcription was completely prevented (Fig. 4,
lane e). However, preincubation of SigB with an excess of albumin did
not affect the transcription (Fig. 4, lane f). Similarly, preformed
E
B was resistant to the inhibitory effect of RsbW (Fig.
4, lane g).

View larger version (62K):
[in this window]
[in a new window]
|
FIG. 4.
Inhibition of SigB-directed transcription from
sar P3 by RsbW. The transcription reaction mixtures
contained 0.4 U of E. coli core RNA polymerase and 0.02 µg
of DNA template containing the sar P3 promoter. Lanes: a,
core RNA polymerase incubated with dialysis buffer; b, core RNA
polymerase incubated with 0.58 µg of Trx-tagged SigB; c to e,
Trx-tagged SigB incubated with increasing amounts (0.03, 0.12, and 0.36 µg in lanes c, d, and e, respectively) of the Trx-tagged RsbW fusion
protein prior to the addition of core RNA polymerase; f, Trx-tagged
SigB incubated with an excess amount (18 µg) of bovine serum albumin
instead of RsbW prior to the addition of core RNA polymerase; g,
Trx-tagged SigB incubated with core RNA polymerase prior to the
addition of 0.36 µg of RsbW. The products of transcription were
subjected to electrophoresis on a 6% denaturing polyacrylamide gel and
visualized by autoradiography. The arrow indicates the position of the
anticipated sar transcript. Lane M, 32P-labeled
DNA size markers as in Fig. 3.
|
|
Transcription of genes encoding alkaline shock protein 23 and
coagulase is SigB dependent and inhibited by RsbW.
We screened all
S. aureus genes available in the GenBank as of November
1998 for the presence of sequences resembling the B. subtilis SigB promoter consensus (Fig.
5). The search identified putative SigB
promoter sequences upstream of the asp23 gene which encodes
alkaline shock protein 23, and coa gene which encodes coagulase (21, 33) (Fig. 5). To test the SigB dependence of these promoters, we PCR amplified these promoters from S. aureus genomic DNA; SigB-directed in vitro transcription from the
asp23 and coa promoter templates was calculated
to produce 144 and 200 base transcripts, respectively. As shown in Fig.
6, core RNA polymerase reconstituted with
SigB produced a 150-base transcript from the asp23 putative
promoter (Fig. 6, lane b), while core enzyme alone failed to generate a
transcript (Fig. 6, lane a). In the same manner, E
B
produced a 210-nucleotide transcript from the coa gene (Fig. 6, lane f). When an equimolar amount of RsbW was mixed with SigB prior
to the addition of core polymerase, SigB-dependent asp23 and
coa transcription was inhibited almost completely (Fig. 6, lanes c and g). Excess quantities of albumin as a control protein did
not influence the transcription of asp23 and coa
(Fig. 6, lanes d and h).

View larger version (49K):
[in this window]
[in a new window]
|
FIG. 5.
SigB promoter sequences from B. subtilis, L. monocytogenes, and S. aureus. The putative promoter sequences of the asp23
gene and the coa gene are aligned with those of known
SigB-dependent promoters from B. subtilis,
L. monocytogenes, and S. aureus. In
B. subtilis and L. monocytogenes the
SigB-dependent promoters control the sigB operon in part.
|
|

View larger version (81K):
[in this window]
[in a new window]
|
FIG. 6.
SigB-directed transcription of asp23 and
coa and inhibition by RsbW. The transcription reaction
mixtures contained 0.4 U of E. coli core RNA polymerase and
0.02 µg of DNA templates containing the putative promoter region of
asp23 (lanes a to d) and coa (lanes e to h).
Lanes: a and e, no addition; b and f, 0.58 µg of Trx-tagged SigB that
had been preincubated with dialysis buffer; c and g, 0.58 µg of
Trx-tagged SigB that had been preincubated with 0.36 µg of Trx-RsbW
fusion protein; d and h, 0.58 µg of Trx-tagged SigB that had been
preincubated with an excess amount (18 µg) of bovine serum albumin.
The products of transcription were subjected to electrophoresis on a
6% denaturing polyacrylamide gel and visualized by autoradiography.
The arrows indicate the positions of the anticipated transcripts. Lane
M, 32P-labeled DNA size markers as in Fig. 3.
|
|
 |
DISCUSSION |
Anti-sigma factors are posttranslational transcription regulators
which, under appropriate cellular conditions, bind to their cognate
sigma factor and block sigma factor association with core RNA
polymerase. As a result, anti-sigma factors inhibit transcription from
a given regulon by inhibiting the action of a specific sigma factor
(5). In this study we determined that the gene product of
the rsbW (orf159) gene is an anti-sigma factor of
S. aureus SigB. Our data show that RsbW and SigB
are capable of direct protein-protein interaction, as documented by
cross-linking experiments, and that RsbW is a specific inhibitor of
SigB-directed transcription in vitro.
Our cross-linking experiments show the RsbW and SigB interaction to be
relatively specific and indicate that RsbW exists as a dimer in
solution, while SigB is monomeric. This agrees well with the results of
SpoIIAB, an anti-sigma factor of B. subtilis SigF
(9, 15) and UsfX, an anti-sigma factor of
Mycobacterium tuberculosis SigF (unpublished data),
respectively. In spite of its ability to dimerize, RsbW inhibits SigB
with 1:1 stoichiometry, since our in vitro transcription experiments
indicate that equimolar concentrations of RsbW completely blocked
SigB-directed transcription.
Based on sequence comparison, the sar P3 promoter fits the
consensus for SigB-dependent promoters of B. subtilis
(2). We found that, biochemically, the sar
P3 promoter is recognized by SigB, confirming the results
reported by Deora et al. (12). Additionally, we showed that
RsbW prevented SigB-directed transcription from the sar P3
promoter in a concentration-dependent manner.
The similar organization of the sigB operons in
S. aureus and B. subtilis suggests
analogous roles for the RsbV regulatory proteins in addition to RsbW
(22, 40). In B. subtilis, RsbV is an
anti-anti-sigma factor which competes with SigB for
binding to anti-sigma factor RsbW
a mechanism dubbed partner
switching (1, 14). An increased requirement for SigB in
B. subtilis is governed by an increase in polycistronic
transcription of the rsbV-rsbW-sigB-rsbX operon, and
posttranslational mechanisms subsequently determine whether SigB is
active. During normal exponential phase, RsbW inactivates RsbV by
phosphorylation, promoting the formation of RsbW-SigB complexes. In
response to stress or starvation, on the other hand, RsbV is
dephosphorylated and captures the RsbW to form RsbV-RsbW complexes
leading to the release of active SigB (14, 41). In addition
to the operon transcription and partner-switching mechanisms for
modulating sigma factor activity observed in B. subtilis, it has recently been proposed that the S. aureus sigB gene may also be expressed as a monocistronic message,
independent of its upstream regulators during stationary phase
(22). Thus, while some elements of SigB regulatory control
appear to be conserved across species, important differences may be
present. Recently, additional sigB-like operons have been
discovered in Listeria monocytogenes (3, 38) and
M. tuberculosis (10, 11, 30). The L. monocytogenes and M. tuberculosis operons show
similarities in amino acid sequence and gene organization to the
S. aureus and B. subtilis sigB operons,
although the M. tuberculosis SigB-like operon lacks RsbV and
RsbX homologues (11). In view of the apparent differences
among these gram-positive bacteria, it will be important to evaluate
the function of each SigB-like system independently.
Recent studies have characterized S. aureus SigB as a
major regulator of the stress response against environmental changes such as heat shock, oxidative stress, and acid stress (6, 22, 23); however, the SigB-dependent genes responsible for these physiologic adaptations have not been identified. The asp23
gene encoding alkaline shock protein 23 was suggested as a possible target gene of SigB because the expression of Asp23 was affected by
deletion of the entire rsbV-rsbW-sigB-rsbX operon in
S. aureus (23). Expression of Asp23 is
strongly induced upon pH upshift (24). Our in vitro
transcription data support the notion that asp23 is a member
of the S. aureus SigB regulon, although the physiological role of this stress response protein remains uncertain.
We have also found that the coa gene encoding coagulase is
recognized by S. aureus SigB in vitro. Coagulase has
been one of the most reliable determinants for the differentiation of
S. aureus from other, less-virulent staphylococci.
Since several reports have indicated that coagulase-deficient mutants
of S. aureus are attenuated in experimental infections
in mice, coagulase is considered a virulence determinant in the
pathogenesis of S. aureus infections (20, 28, 34,
35). In culture, coagulase is preferentially expressed in early
to late exponential phase. While coagulase deficiency did not appear to
influence the course of valvular infection in the rat endocarditis
model (32), coagulase was important for the establishment of
lung infection in a model promoting pulmonary abscess formation
(34). These different observations imply that coagulase
expression may participate in later stages of infection and that
SigB-dependent genes may be important for the abscess formation and
survival in a purulent, microaerophilic environment. The role of
S. aureus sigB in pathogenicity has been examined in
one study with the mouse subcutaneous abscess model. While the analysis
revealed no difference in virulence between a sigB mutant
and the corresponding parent strain (6), it has been noted
that the wild-type strain used (S. aureus 8325-4)
contains an 11-bp deletion in the regulatory gene rsbU
(22, 23) and may itself be attenuated.
As the S. aureus SigB regulon contains genes which have
been associated with virulence, studies to clarify the role of SigB in
the infection process and to identify more of the genes under its
control may offer valuable insight into staphylococcal adaptive mechanisms. Since RsbW is a natural inhibitor of a virulence-associated transcription factor, it is possible that pharmacologic analogues of
RsbW could have novel antibacterial properties against this important
medical pathogen.
 |
ADDENDUM |
We recently tested whether RsbW had an inhibitory effect on in
vitro transcription from the sar locus by a holoenzyme other than E
B. We found that commercially available E. coli
70 (Epicentre Technologies, Madison, Wis.)
associated with E. coli core RNA polymerase by the same
methods described above was able to direct in vitro transcription from
the S. aureus sar P2 promoter. Preincubation with
purified RsbW or with albumin did not affect the level of
E
70-directed in vitro transcription from this promoter.
These results provide additional support for the conclusion that RsbW
is a specific anti-sigma factor for S. aureus SigB.
 |
ACKNOWLEDGMENTS |
We thank Richard Novick for providing S. aureus
strains. We are grateful to Miki Miyazaki for excellent technical
assistance and to Jennifer Doetsch for assistance in manuscript preparation.
This work was supported in part by NIH grants AI36973 and AI37856.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Center for
Tuberculosis Research, Johns Hopkins School of Public Health, 615 N. Wolfe St., Baltimore, MD 21205-2179. Phone: (410) 955-3507. Fax: (410) 614-8173. E-mail: wbishai{at}jhsph.edu.
 |
REFERENCES |
| 1.
|
Alper, S.,
L. Duncan, and R. Losick.
1994.
An adenosine nucleotide switch controlling the activity of a cell type-specific transcription factor in B. subtilis.
Cell
77:195-205[Medline].
|
| 2.
|
Bayer, M. G.,
J. H. Heinrichs, and A. L. Cheung.
1996.
The molecular architecture of the sar locus in Staphylococcus aureus.
J. Bacteriol.
178:4563-4570[Abstract/Free Full Text].
|
| 3.
|
Becker, L. A.,
M. Cetin,
R. W. Hutkins, and A. K. Benson.
1998.
Identification of the gene encoding the alternative sigma factor B from Listeria monocytogenes and its role in osmotolerance.
J. Bacteriol.
180:4547-4554[Abstract/Free Full Text].
|
| 4.
|
Benson, A. K., and W. G. Haldenwang.
1993.
Bacillus subtilis B is regulated by a binding protein (RsbW) that blocks its association with core RNA polymerase.
Proc. Natl. Acad. Sci. USA
90:2330-2334[Abstract/Free Full Text].
|
| 5.
|
Brown, K. L., and K. T. Hughes.
1995.
The role of anti-sigma factors in gene regulation.
Mol. Microbiol.
16:397-404[Medline].
|
| 6.
|
Chan, P. F.,
S. J. Foster,
E. Ingham, and M. O. Clements.
1998.
The Staphylococcus aureus alternative sigma factor B controls the environmental stress response but not starvation survival or pathogenicity in a mouse abscess model.
J. Bacteriol.
180:6082-6089[Abstract/Free Full Text].
|
| 7.
|
Cheung, A. L.,
J. M. Koomey,
C. A. Butler,
S. J. Projan, and V. A. Fischetti.
1992.
Regulation of exoprotein expression in Staphylococcus aureus by a locus (sar) distinct from agr.
Proc. Natl. Acad. Sci. USA
89:6462-6466[Abstract/Free Full Text].
|
| 8.
|
Cheung, A. L., and P. Ying.
1994.
Regulation of - and -hemolysins by the sar locus of Staphylococcus aureus.
J. Bacteriol.
176:580-585[Abstract/Free Full Text].
|
| 9.
|
Decatur, A. L., and R. Losick.
1996.
Three sites of contact between the Bacillus subtilis transcription factor F and its antisigma factor SpoIIAB.
Genes Dev.
10:2348-2358[Abstract/Free Full Text].
|
| 10.
|
DeMaio, J.,
Y. Zhang,
C. Ko,
D. B. Young, and W. R. Bishai.
1996.
A stationary-phase stress-response sigma factor from Mycobacterium tuberculosis.
Proc. Natl. Acad. Sci. USA
93:2790-2794[Abstract/Free Full Text].
|
| 11.
|
DeMaio, J.,
Y. Zhang,
C. Ko, and W. R. Bishai.
1997.
The Mycobacterium tuberculosis sigF gene is part of a gene cluster with similarities to the Bacillus subtilis sigF and sigB operons.
Tubercle Lung Dis.
78:3-12[Medline].
|
| 12.
|
Deora, R.,
T. Tseng, and T. K. Misra.
1997.
Alternative transcription factor SB of Staphylococcus aureus: characterization and role in transcription of the global regulatory locus sar.
J. Bacteriol.
179:6355-6359[Abstract/Free Full Text].
|
| 13.
|
Deretic, V.,
M. J. Schurr,
J. C. Boucher, and D. W. Martin.
1994.
Conversion of Pseudomonas aeruginosa to mucoidy in cystic fibrosis: environmental stress and regulation of bacterial virulence by alternative sigma factors.
J. Bacteriol.
176:2773-2780[Free Full Text].
|
| 14.
|
Dufour, A., and W. G. Haldenwang.
1994.
Interactions between a Bacillus subtilis anti- factor (RsbW) and its antagonist (RsbV).
J. Bacteriol.
176:1813-1820[Abstract/Free Full Text].
|
| 15.
|
Duncan, L., and R. Losick.
1993.
SpoIIAB is an anti-sigma factor that binds to and inhibits transcription by regulatory protein sigma F from Bacillus subtilis.
Proc. Natl. Acad. Sci. USA
15:2325-2329.
|
| 16.
|
Emori, T. G., and R. P. Gayner.
1993.
An overview of nosocomial infections, including the role of the microbiology laboratory.
Clin. Microbiol. Rev.
6:428-442[Abstract/Free Full Text].
|
| 17.
|
Fang, F. C.,
S. J. Libby,
N. A. Buchmeier,
P. C. Loewen,
J. Switala,
J. Harwood, and D. G. Guiney.
1992.
The alternative factor KatF (RpoS) regulates Salmonella virulence.
Proc. Natl. Acad. Sci. USA
89:11978-11982[Abstract/Free Full Text].
|
| 18.
|
Gillen, K. L., and K. T. Hughes.
1991.
Molecular characterization of flgM, a gene encoding a negative regulator of flagellin synthesis in Salmonella typhimurium.
J. Bacteriol.
173:6453-6459[Abstract/Free Full Text].
|
| 19.
|
Hughes, K. T., and K. Mathee.
1998.
The anti-sigma factors.
Annu. Rev. Microbiol.
52:231-286[Medline].
|
| 20.
|
Jonsson, P.,
M. Lindberg,
I. Haraldsson, and T. Wadström.
1985.
Virulence of Staphylococcus aureus in a mouse mastitis model: studies of alpha hemolysin, coagulase, and protein A as possible virulence determinants with protoplast fusion and gene cloning.
Infect. Immun.
49:765-769[Abstract/Free Full Text].
|
| 21.
|
Kaida, S.,
T. Miyata,
Y. Yoshizawa,
S. Kawabata,
T. Morita,
H. Igarashi, and S. Iwanaga.
1987.
Nucleotide sequence of the staphylocoagulase gene: its unique COOH-terminal 8 tandem repeats.
J. Biochem.
102:1177-1186[Abstract/Free Full Text].
|
| 22.
|
Kullik, I., and P. Giachino.
1997.
The alternative sigma factor sigma B in Staphylococcus aureus: regulation of the sigB operon in response to growth phase and heat shock.
Arch. Microbiol.
167:151-159[Medline].
|
| 23.
|
Kullik, I.,
P. Giachino, and T. Fuchs.
1998.
Deletion of the alternative sigma factor B in Staphylococcus aureus reveals its function as a global regulator of virulence genes.
J. Bacteriol.
180:4814-4820[Abstract/Free Full Text].
|
| 24.
|
Kuroda, M.,
T. Ohta, and H. Hayashi.
1995.
Isolation and the gene cloning of an alkaline shock protein in methicillin-resistant Staphylococcus aureus.
Biochem. Biophys. Res. Commun.
207:978-984[Medline].
|
| 25.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature
227:680-685[Medline].
|
| 26.
|
Lowy, F. D.
1998.
Staphylococcus aureus infections.
N. Engl. J. Med.
339:520-532[Free Full Text].
|
| 27.
|
Manna, A. C.,
M. G. Bayer, and A. L. Cheung.
1998.
Transcriptional analysis of different promoters in the sar locus in Staphylococcus aureus.
J. Bacteriol.
180:3828-3836[Abstract/Free Full Text].
|
| 28.
|
Masuda, S.
1983.
An efficient method for the isolation of a mutant with an extremely low producibility of coagulase from a Staphylococcus aureus strain.
Microbiol. Immunol.
27:801-805[Medline].
|
| 29.
|
Mekalanos, J. J.
1992.
Environmental signals controlling expression of virulence determinants in bacteria.
J. Bacteriol.
174:1-7[Free Full Text].
|
| 30.
|
Michele, T. M.,
C. Ko, and W. R. Bishai.
1999.
Exposure to antibiotics induces expression of the Mycobacterium tuberculosis sigF gene: implications for chemotherapy against mycobacterial persistors.
Antimicrob. Agents Chemother.
43:218-225[Abstract/Free Full Text].
|
| 31.
|
Min, K. T.,
C. M. Hilditch,
B. Diederich,
J. Errington, and M. D. Yudkin.
1993.
F, the first compartment-specific transcription factor of B. subtilis, is regulated by an anti- factor that is also a protein kinase.
Cell
74:735-742[Medline].
|
| 32.
|
Moreillon, P.,
J. M. Entenza,
P. Francioli,
D. McDevitt,
T. J. Foster,
P. Francois, and P. Vaudaux.
1995.
Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis.
Infect. Immun.
63:4738-4743[Abstract].
|
| 33.
|
Phonimdaeng, P.,
M. O'Reilly,
P. Nowlan,
A. J. Bramley, and T. J. Foster.
1990.
The coagulase of Staphylococcus aureus 8325-4. Sequence analysis and virulence of site-specific coagulase-deficient mutants.
Mol. Microbiol.
4:393-404[Medline].
|
| 34.
|
Sawai, T.,
K. Tomono,
K. Yanagihara,
Y. Yamamoto,
M. Kaku,
Y. Hirakata,
H. Koga,
T. Tashiro, and S. Kohno.
1997.
Role of coagulase in a murine model of hematogenous pulmonary infection induced by intravenous injection of Staphylococcus aureus enmeshed in agar beads.
Infect. Immun.
65:466-471[Abstract].
|
| 35.
|
Seki, K.,
M. Ogasawara,
J. Sakurada,
M. Murai, and S. Masuda.
1989.
Altered virulence of a pleiotropic Staphylococcus aureus mutant with low producibility of coagulase and other factors in mice.
Microbiol. Immunol.
33:981-990[Medline].
|
| 36.
|
Sheagren, J. N.
1984.
Staphylococcus aureus: the persistent pathogen.
N. Engl. J. Med.
310:1368-1373[Medline].
|
| 37.
|
Speller, D. C. E.,
A. P. Johnson,
D. James,
R. R. Marples,
A. Charlett, and R. C. George.
1997.
Resistance to methicillin and other antibiotics in isolates of Staphylococcus aureus from blood and cerebrospinal fluid, England and Wales, 1989-95.
Lancet
350:323-325[Medline].
|
| 38.
|
Wiedmann, M.,
T. J. Arvik,
R. J. Hurley, and K. J. Boor.
1998.
General stress transcription factor B and its role in acid tolerance and virulence of Listeria monocytogenes.
J. Bacteriol.
180:3650-3656[Abstract/Free Full Text].
|
| 39.
|
Wilkinson, B. J.
1997.
Biology, p. 1-38.
In
K. B. Crossley, and G. L. Archer (ed.), The staphylococci in human disease. Churchill Livingstone, New York, N.Y.
|
| 40.
|
Wu, S.,
H. de Lencastre, and A. Tomasz.
1996.
Sigma-B, a putative operon encoding alternate sigma factor of Staphylococcus aureus RNA polymerase: molecular cloning and DNA sequencing.
J. Bacteriol.
178:6036-6042[Abstract/Free Full Text].
|
| 41.
|
Yang, X.,
C. M. Kang,
M. S. Brody, and C. W. Price.
1996.
Opposing pairs of serine protein kinases and phosphatases transmit signals of environmental stress to activate a bacterial transcription factor.
Genes Dev.
10:2265-2275[Abstract/Free Full Text].
|
Journal of Bacteriology, May 1999, p. 2846-2851, Vol. 181, No. 9
0021-9193/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Cheung, A. L., Nishina, K., Manna, A. C.
(2008). SarA of Staphylococcus aureus Binds to the sarA Promoter To Regulate Gene Expression. J. Bacteriol.
190: 2239-2243
[Abstract]
[Full Text]
-
Bore, E., Langsrud, S., Langsrud, O., Rode, T. M., Holck, A.
(2007). Acid-shock responses in Staphylococcus aureus investigated by global gene expression analysis. Microbiology
153: 2289-2303
[Abstract]
[Full Text]
-
Williams, E. P., Lee, J.-H., Bishai, W. R., Colantuoni, C., Karakousis, P. C.
(2007). Mycobacterium tuberculosis SigF Regulates Genes Encoding Cell Wall-Associated Proteins and Directly Regulates the Transcriptional Regulatory Gene phoY1. J. Bacteriol.
189: 4234-4242
[Abstract]
[Full Text]
-
Oscarsson, J., Kanth, A., Tegmark-Wisell, K., Arvidson, S.
(2006). SarA Is a Repressor of hla ({alpha}-Hemolysin) Transcription in Staphylococcus aureus: Its Apparent Role as an Activator of hla in the Prototype Strain NCTC 8325 Depends on Reduced Expression of sarS. J. Bacteriol.
188: 8526-8533
[Abstract]
[Full Text]
-
Palma, M., Bayer, A., Kupferwasser, L. I., Joska, T., Yeaman, M. R., Cheung, A.
(2006). Salicylic Acid Activates Sigma Factor B by rsbU-Dependent and -Independent Mechanisms.. J. Bacteriol.
188: 5896-5903
[Abstract]
[Full Text]
-
Kazmierczak, M. J., Wiedmann, M., Boor, K. J.
(2005). Alternative Sigma Factors and Their Roles in Bacterial Virulence. Microbiol. Mol. Biol. Rev.
69: 527-543
[Abstract]
[Full Text]
-
Senn, M. M., Giachino, P., Homerova, D., Steinhuber, A., Strassner, J., Kormanec, J., Fluckiger, U., Berger-Bachi, B., Bischoff, M.
(2005). Molecular Analysis and Organization of the {sigma}B Operon in Staphylococcus aureus. J. Bacteriol.
187: 8006-8019
[Abstract]
[Full Text]
-
Senn, M. M., Bischoff, M., von Eiff, C., Berger-Bachi, B.
(2005). {sigma}B Activity in a Staphylococcus aureus hemB Mutant. J. Bacteriol.
187: 7397-7406
[Abstract]
[Full Text]
-
Jager, S., Mack, D., Rohde, H., Horstkotte, M. A., Knobloch, J. K.-M.
(2005). Disintegration of Staphylococcus epidermidis Biofilms under Glucose-Limiting Conditions Depends on the Activity of the Alternative Sigma Factor {sigma}B. Appl. Environ. Microbiol.
71: 5577-5581
[Abstract]
[Full Text]
-
Kozak, N. A., Mattoo, S., Foreman-Wykert, A. K., Whitelegge, J. P., Miller, J. F.
(2005). Interactions between Partner Switcher Orthologs BtrW and BtrV Regulate Type III Secretion in Bordetella. J. Bacteriol.
187: 5665-5676
[Abstract]
[Full Text]
-
van Schaik, W., Tempelaars, M. H., Zwietering, M. H., de Vos, W. M., Abee, T.
(2005). Analysis of the Role of RsbV, RsbW, and RsbY in Regulating {sigma}B Activity in Bacillus cereus. J. Bacteriol.
187: 5846-5851
[Abstract]
[Full Text]
-
Goerke, C., Fluckiger, U., Steinhuber, A., Bisanzio, V., Ulrich, M., Bischoff, M., Patti, J. M., Wolz, C.
(2005). Role of Staphylococcus aureus Global Regulators sae and {sigma}B in Virulence Gene Expression during Device-Related Infection. Infect. Immun.
73: 3415-3421
[Abstract]
[Full Text]
-
Harraghy, N., Kormanec, J., Wolz, C., Homerova, D., Goerke, C., Ohlsen, K., Qazi, S., Hill, P., Herrmann, M.
(2005). sae is essential for expression of the staphylococcal adhesins Eap and Emp. Microbiology
151: 1789-1800
[Abstract]
[Full Text]
-
Li, D., Renzoni, A., Estoppey, T., Bisognano, C., Francois, P., Kelley, W. L., Lew, D. P., Schrenzel, J., Vaudaux, P.
(2005). Induction of Fibronectin Adhesins in Quinolone-Resistant Staphylococcus aureus by Subinhibitory Levels of Ciprofloxacin or by Sigma B Transcription Factor Activity Is Mediated by Two Separate Pathways. Antimicrob. Agents Chemother.
49: 916-924
[Abstract]
[Full Text]
-
Conlon, K. M., Humphreys, H., O'Gara, J. P.
(2004). Inactivations of rsbU and sarA by IS256 Represent Novel Mechanisms of Biofilm Phenotypic Variation in Staphylococcus epidermidis. J. Bacteriol.
186: 6208-6219
[Abstract]
[Full Text]
-
Renzoni, A., Francois, P., Li, D., Kelley, W. L., Lew, D. P., Vaudaux, P., Schrenzel, J.
(2004). Modulation of Fibronectin Adhesins and Other Virulence Factors in a Teicoplanin-Resistant Derivative of Methicillin-Resistant Staphylococcus aureus. Antimicrob. Agents Chemother.
48: 2958-2965
[Abstract]
[Full Text]
-
Knobloch, J. K.-M., Jager, S., Horstkotte, M. A., Rohde, H., Mack, D.
(2004). RsbU-Dependent Regulation of Staphylococcus epidermidis Biofilm Formation Is Mediated via the Alternative Sigma Factor {sigma}B by Repression of the Negative Regulator Gene icaR. Infect. Immun.
72: 3838-3848
[Abstract]
[Full Text]
-
Bischoff, M., Dunman, P., Kormanec, J., Macapagal, D., Murphy, E., Mounts, W., Berger-Bachi, B., Projan, S.
(2004). Microarray-Based Analysis of the Staphylococcus aureus {sigma}B Regulon. J. Bacteriol.
186: 4085-4099
[Abstract]
[Full Text]
-
Karlsson, A., Arvidson, S.
(2002). Variation in Extracellular Protease Production among Clinical Isolates of Staphylococcus aureus Due to Different Levels of Expression of the Protease Repressor sarA. Infect. Immun.
70: 4239-4246
[Abstract]
[Full Text]
-
Palma, M., Cheung, A. L.
(2001). sigma B Activity in Staphylococcus aureus Is Controlled by RsbU and an Additional Factor(s) during Bacterial Growth. Infect. Immun.
69: 7858-7865
[Abstract]
[Full Text]
-
Raman, S., Song, T., Puyang, X., Bardarov, S., Jacobs, W. R. Jr., Husson, R. N.
(2001). The Alternative Sigma Factor SigH Regulates Major Components of Oxidative and Heat Stress Responses in Mycobacterium tuberculosis. J. Bacteriol.
183: 6119-6125
[Abstract]
[Full Text]
-
Herbert, S., Barry, P., Novick, R. P.
(2001). Subinhibitory Clindamycin Differentially Inhibits Transcription of Exoprotein Genes in Staphylococcus aureus. Infect. Immun.
69: 2996-3003
[Abstract]
[Full Text]
-
Knobloch, J. K.-M., Bartscht, K., Sabottke, A., Rohde, H., Feucht, H.-H., Mack, D.
(2001). Biofilm Formation by Staphylococcus epidermidis Depends on Functional RsbU, an Activator of the sigB Operon: Differential Activation Mechanisms Due to Ethanol and Salt Stress. J. Bacteriol.
183: 2624-2633
[Abstract]
[Full Text]
-
Giachino, P., Engelmann, S., Bischoff, M.
(2001). {sigma}B Activity Depends on RsbU in Staphylococcus aureus. J. Bacteriol.
183: 1843-1852
[Abstract]
[Full Text]
-
Manna, A., Cheung, A. L.
(2001). Characterization of sarR, a Modulator of sar Expression in Staphylococcus aureus. Infect. Immun.
69: 885-896
[Abstract]
[Full Text]
-
Gertz, S., Engelmann, S., Schmid, R., Ziebandt, A.-K., Tischer, K., Scharf, C., Hacker, J., Hecker, M.
(2000). Characterization of the sigma B Regulon in Staphylococcus aureus. J. Bacteriol.
182: 6983-6991
[Abstract]
[Full Text]
-
Rachid, S., Ohlsen, K., Wallner, U., Hacker, J., Hecker, M., Ziebuhr, W.
(2000). Alternative Transcription Factor sigma B Is Involved in Regulation of Biofilm Expression in a Staphylococcus aureus Mucosal Isolate. J. Bacteriol.
182: 6824-6826
[Abstract]
[Full Text]
-
Chakrabarti, S. K., Misra, T. K.
(2000). SarA Represses agr Operon Expression in a Purified In Vitro Staphylococcus aureus Transcription System. J. Bacteriol.
182: 5893-5897
[Abstract]
[Full Text]
-
Fouet, A., Namy, O., Lambert, G.
(2000). Characterization of the Operon Encoding the Alternative sigma B Factor from Bacillus anthracis and Its Role in Virulence. J. Bacteriol.
182: 5036-5045
[Abstract]
[Full Text]
-
Novick, R. P., Ross, H. F., Figueiredo, A. M., Abramochkin, G., Muir;, T., Balaban, N., Singh, B., Goldkorn, T., Rasooly, A., Torres, J. V., Uziel;, O.
(2000). Activation and Inhibition of the Staphylococcal AGR System. Science
287: 391a-391
[Full Text]